ASCO 2022 Conference Coverage

 

ASCO 2022 Conference Coverage
U

Lecture Summary - ASCO 2022 on the Phase III frontMIND Study: Tafasitamab + Lenalidomide + R-CHOP vs. R-CHOP Alone for Newly Diagnosed High-Intermediate & High-Risk DLBCL

By ASCO 2022 Conference Coverage FEATURING Umberto Vitolo
By ASCO 2022 Conference Coverage FEATURING Umberto Vitolo
42 views
June 24, 2022
Comments 0
Login to view comments. Click here to Login
Lymphoma
04:26

2022 ASCO Annual Meeting "The Effects of AVM0703 Mobilization of End…

ASCO 2022 Conference Coverage

J. Dalpez

121 views
01:07

Lecture Summary - ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequen…

ASCO 2022 Conference Coverage

J. Winter

42 views
09:39

ASCO 2022 on the Phase 2 KEYNOTE-C11 Study: Sequential Pembro & Chem…

ASCO 2022 Conference Coverage

J. Winter

13 views
01:13

Lecture Summary - ASCO 2022 on the Phase III frontMIND Study: Tafasi…

ASCO 2022 Conference Coverage

U. Vitolo

42 views
08:45

ASCO 2022 on the Phase III frontMIND Study: Tafasitamab + Lenalidomi…

ASCO 2022 Conference Coverage

U. Vitolo

23 views
08:55

ASCO 2022 on the Analysis of Peripheral Neuropathy in 1L DLBCL Using…

ASCO 2022 Conference Coverage

M. Trneny

23 views
10:16

ASCO 2022 ADCs and CARs: Racing to Cure Aggresive Lymphoma

ASCO 2022 Conference Coverage

K. Patel

85 views
13:02

ASCO 2022 on the Predictive Value of TGFβ1/TGFBR2 Ratio for Evaluati…

ASCO 2022 Conference Coverage

V. Bandovkina

107 views
11:30

ASCO 2022 Expert Discussion: Current Treatment Approaches in Hemophi…

ASCO 2022 Conference Coverage

J. Bussel, C. Mcguinn

55 views
01:44

Lecture Summary - ASCO 2022 Treatment Patterns and Real-World Effect…

ASCO 2022 Conference Coverage

M. Di

8 views
05:39

ASCO 2022 Treatment Patterns and Real-World Effectiveness of Rituxim…

ASCO 2022 Conference Coverage

M. Di

102 views
05:16

ASCO 2022 Three-Year Follow-Up of Outcomes With KTE-X19 in R/R Mantl…

ASCO 2022 Conference Coverage

M. Wang

94 views
53

Lecture Summary - ASCO 2022 Three-Year Follow-Up of Outcomes With KT…

ASCO 2022 Conference Coverage

M. Wang

33 views
05:40

ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle Cell Lymphoma: Re…

ASCO 2022 Conference Coverage

P. Jain

87 views
57

Lecture Summary - ASCO 2022 Brexucabtagene Autoleucel for R/R Mantle…

ASCO 2022 Conference Coverage

P. Jain

13 views
07:46

ASCO 2022 on the Initial Safety Run-in Results of the Phase III POLA…

ASCO 2022 Conference Coverage

M. Matasar

77 views
03:32

ASCO 2022 Correlates of Common Concerns in Older Cancer Survivors of…

ASCO 2022 Conference Coverage

M. Loh

19 views
52

Lecture Summary - ASCO 2022 Real World Experience of Combined Treatm…

ASCO 2022 Conference Coverage

M. Kalac

18 views
12:56

ASCO 2022 Real World Experience of Combined Treatment With Romidepsi…

ASCO 2022 Conference Coverage

M. Kalac

16 views
01:33

Lecture Summary - ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as …

ASCO 2022 Conference Coverage

J. Abeykoon

102 views
10:06

ASCO 2022 Bendamustine Rituximab vs. Ibrutinib as Primary Therapy fo…

ASCO 2022 Conference Coverage

J. Abeykoon

1.7K views
42

Lecture Summary - ASCO 2022 on Clinical & PROs in a Phase III, Rando…

ASCO 2022 Conference Coverage

J. Westin

24 views
05:27

ASCO 2022 on Clinical & PROs in a Phase III, Randomized, Open-Label …

ASCO 2022 Conference Coverage

J. Westin

58 views
04:35

ASCO 2022 on CRC-403: A Phase 1/2 Study of bbT369, A Dual Targeting …

ASCO 2022 Conference Coverage

F. Locke

52 views
34

Lecture Summary - ASCO 2022 Updated Interim Analysis of the Randomiz…

ASCO 2022 Conference Coverage

C. Lee Batlevi

19 views
05:16

ASCO 2022 Updated Interim Analysis of the Randomized Phase 1b/3 Stud…

ASCO 2022 Conference Coverage

C. Lee Batlevi

64 views
05:13

ASCO 2022 PACIFIC Trial Updates: Response Kinetics, Safety & Efficac…

ASCO 2022 Conference Coverage

R. Steiner

414 views